PPARα/HNF4α interplay on diversified responsive elements. Relevance in the regulation of liver peroxisomal fatty acid catabolism

Current Drug Metabolism

Volumn 13, Issue 10, 2012, Pages 1436-1453

  Chamouton, Julie ^a,b   Latruffe, Norbert ^a,b,c  

^a Faculté des Sciences Gabriel   (France)

^b Institut Médical de Génétique et d Immunologie   (France)

^c UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

Fatty acid catabolism; HNF4 ; Peroxisomal oxidation enzymes; PPAR ; Response element

Indexed keywords

ABC TRANSPORTER; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; CARNITINE PALMITOYLTRANSFERASE I; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYTOCHROME P450; CYTOCHROME P450 4A; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A LYASE; HYDROXYMETHYLGLUTARYL COENZYME A SYNTHASE; LEUKOTRIENE B4; LIPOPROTEIN LIPASE; LONG CHAIN FATTY ACID COENZYME A LIGASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PHOSPHOLIPID TRANSFER PROTEIN; PREGNANE X RECEPTOR; PROTEIN P21; RECEPTOR INTERACTING PROTEIN 140; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR ALPHA; SCAVENGER RECEPTOR BI; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR; STEROID RECEPTOR COACTIVATOR 1; STEROID RECEPTOR COACTIVATOR 3; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; THYROID HORMONE RECEPTOR; UNINDEXED DRUG;

ALPHA HELIX; ARTICLE; BETA SHEET; BILE ACID METABOLISM; CATABOLISM; CHOLESTEROL METABOLISM; CHROMATIN STRUCTURE; DNA BINDING; DNA RESPONSIVE ELEMENT; DNA SEQUENCE; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY LIVER; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; GLUCOSE METABOLISM; HUMAN; IMMUNOPRECIPITATION; LIGAND BINDING; LIPID METABOLISM; LIPOPROTEIN METABOLISM; LIVER CANCER; MOLECULAR INTERACTION; PEROXISOME; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN STRUCTURE;

ANIMALS; FATTY ACIDS; GENE EXPRESSION REGULATION; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; LIVER; PEROXISOMES; PPAR ALPHA; RESPONSE ELEMENTS;

EID: 84870471297     PISSN: 13892002     EISSN: 18755453     Source Type: Journal    
DOI: 10.2174/138920012803762738     Document Type: Article

References (217)

1. Lazarow, P.B.; De Duve, C. A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug. Proc. Natl Acad. Sci. USA, 1976, 73, 2043-2046.
2. Wanders, R.J.; Waterham, H.R. Peroxisomal disorders: the single peroxisomal enzyme deficiencies. Biochim. Biophys. Acta, 2006, 1763, 1707-1720.
3. Issemann, I.; Green, S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature, 1990, 347, 645-650.
4. Dreyer, C.; Krey, G.; Keller, H.; Givel, F.; Helftenbein, G.; Wahli, W. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell, 1992, 68, 879-887.
5. Chawla, A.; Repa, J.J.; Evans, R.M.; Mangelsdorf, D.J. Nuclear receptors and lipid physiology: opening the X-files. Science, 2001, 294, 1866-1870.
6. Krey, G.; Braissant, O.; L'Horset, F.; Kalkhoven, E.; Perroud, M.; Parker, M.G.; Wahli, W. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol., 1997, 11, 779-791.
7. Desvergne, B.; Wahli, W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev., 1999, 20, 649-688.
8. Dowell, P.; Ishmael, J.E.; Avram, D.; Peterson, V.J.; Nevrivy, D.J.; Leid, M. Identification of nuclear receptor corepressor as a peroxisome proliferator-activated receptor alpha interacting protein. J. Biol. Chem., 1999, 274, 15901-15907.
9. Xu, H.E.; Lambert, M.H.; Montana, V.G.; Plunket, K.D.; Moore, L.B.; Collins, J.L.; Oplinger, J.A.; Kliewer, S.A.; Gampe, R.T., Jr.; McKee, D.D., et al. Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors. Proc. Natl Acad. Sci. USA, 2001, 98, 13919-13924.
10. Tugwood, J.D.; Issemann, I.; Anderson, R.G.; Bundell, K.R.; McPheat, W.L.; Green, S. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl CoA oxidase gene. EMBO J., 1992, 11, 433-439.
11. van der Meer, D.L.; Degenhardt, T.; Vaisanen, S.; de Groot, P.J.; Heinaniemi, M.; de Vries, S.C.; Muller, M.; Carlberg, C.; Kersten, S. Profiling of promoter occupancy by PPARalpha in human hepatoma cells via ChIP-chip analysis. Nucl. Ac. Res, 2010, 38, 2839-2850.
12. Zhang, B.; Marcus, S.L.; Sajjadi, F.G.; Alvares, K.; Reddy, J.K.; Subramani, S.; Rachubinski, R.A.; Capone, J.P. Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase. Proc. Natl Acad. Sci. USA, 1992, 89, 7541-7545.
13. Wen, G.; Ringseis, R.; Eder, K. Mouse OCTN2 is directly regulated by peroxisome proliferator-activated receptor alpha (PPARalpha) via a PPRE located in the first intron. Biochem. Pharmacol., 2010, 79, 768-776.
14. Hansmannel, F.; Clemencet, M.C.; Le Jossic-Corcos, C.; Osumi, T.; Latruffe, N.; Nicolas-Frances, V. Functional characterization of a peroxisome proliferator response-element located in the intron 3 of rat peroxisomal thiolase B gene. Biochem. Biophys. Res. Commun, 2003, 311, 149-155.
15. Juge-Aubry, C.; Pernin, A.; Favez, T.; Burger, A.G.; Wahli, W.; Meier, C.A.; Desvergne, B. DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5′-flanking region. J. Biol. Chem., 1997, 272, 25252-25259.
16. IJpenberg, A.; Jeannin, E.; Wahli, W.; Desvergne, B. Polarity and specific sequence requirements of peroxisome proliferator-activated receptor (PPAR)/retinoid X receptor heterodimer binding to DNA. A functional analysis of the malic enzyme gene PPAR response element. J. Biol. Chem., 1997, 272, 20108-20117.
17. Bugge, T.H.; Pohl, J.; Lonnoy, O.; Stunnenberg, H.G. RXR alpha, a promiscuous partner of retinoic acid and thyroid hormone receptors. EMBO J., 1992, 11, 1409-1418.
18. Juge-Aubry, C.E.; Gorla-Bajszczak, A.; Pernin, A.; Lemberger, T.; Wahli, W.; Burger, A.G.; Meier, C.A. Peroxisome proliferator-activated receptor mediates cross-talk with thyroid hormone receptor by competition for retinoid X receptor. Possible role of a leucine zipper-like heptad repeat. J. Biol. Chem., 1995, 270, 18117-18122.
19. Mangelsdorf, D.J.; Evans, R.M. The RXR heterodimers and orphan receptors. Cell, 1995, 83, 841-850.
20. Chu, R.; Lin, Y.; Rao, M.S.; Reddy, J.K. Cooperative formation of higher order peroxisome proliferator-activated receptor and retinoid X receptor complexes on the peroxisome proliferator responsive element of the rat hydratase-dehydrogenase gene. J. Biol. Chem., 1995, 270, 29636-29639.
21. Jow, L.; Mukherjee, R. The human peroxisome proliferator-activated receptor (PPAR) subtype NUC1 represses the activation of hPPAR alpha and thyroid hormone receptors. J. Biol. Chem., 1995, 270, 3836-3840.
22. IJpenberg, A.; Tan, N.S.; Gelman, L.; Kersten, S.; Seydoux, J.; Xu, J.; Metzger, D.; Canaple, L.; Chambon, P.; Wahli, W., et al. In vivo activation of PPAR target genes by RXR homodimers. EMBO J., 2004, 23, 2083-2091.
23. Feige, J.N.; Gelman, L.; Michalik, L.; Desvergne, B.; Wahli, W. From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Progr. Lipid Res., 2006, 45, 120-159.
24. Yu, S.; Reddy, J.K. Transcription coactivators for peroxisome proliferator-activated receptors. Biochim. Biophys. Acta, 2007, 1771, 936-951.
25. Zoete, V.; Grosdidier, A.; Michielin, O. Peroxisome proliferator- activated receptor structures: ligand specificity, molecular switch and interactions with regulators. Biochim. Biophys. Acta, 2007, 1771, 915-925.
26. Collingwood, T.N.; Urnov, F.D.; Wolffe, A.P. Nuclear receptors: coactivators, corepressors and chromatin remodeling in the control of transcription. J. Mol. Endo., 1999, 23, 255-275.
27. Burke, L.J.; Baniahmad, A. Co-repressors 2000. FASEB J., 2000, 14, 1876-1888.
28. Hu, X.; Lazar, M.A. Transcriptional repression by nuclear hormone receptors. Trends Endocrinol. Metab., 2000, 11, 6-10.
29. White, J.H.; Fernandes, I.; Mader, S.; Yang, X.J. Corepressor recruitment by agonist-bound nuclear receptors. Vitam. Horm., 2004, 68, 123-143.
30. Viswakarma, N.; Jia, Y.; Bai, L.; Vluggens, A.; Borensztajn, J.; Xu, J.; Reddy, J.K. Coactivators in PPAR-Regulated Gene Expression. PPAR Res., 2010, 2010.
31. Jia, Y.; Qi, C.; Kashireddi, P.; Surapureddi, S.; Zhu, Y.J.; Rao, M.S.; Le Roith, D.; Chambon, P.; Gonzalez, F.J.; Reddy, J.K. Transcription coactivator PBP, the peroxisome proliferator-activated receptor (PPAR)-binding protein, is required for PPARalpha-regulated gene expression in liver. J. Biol. Chem., 2004, 279, 24427-24434.
32. Surapureddi, S.; Viswakarma, N.; Yu, S.; Guo, D.; Rao, M.S.; Reddy, J.K. PRIC320, a transcription coactivator, isolated from peroxisome proliferator-binding protein complex. Biochem. Biophys. Res. Commun., 2006, 343, 535-543.
33. Surapureddi, S.; Yu, S.; Bu, H.; Hashimoto, T.; Yeldandi, A.V.; Kashireddy, P.; Cherkaoui-Malki, M.; Qi, C.; Zhu, Y.J.; Rao, M.S., et al. Identification of a transcriptionally active peroxisome proliferator-activated receptor alpha -interacting cofactor complex in rat liver and characterization of PRIC285 as a coactivator. Proc. Natl Acad. Sci. USA, 2002, 99, 11836-11841.
34. Lin, J.; Puigserver, P.; Donovan, J.; Tarr, P.; Spiegelman, B.M. Peroxisome proliferator-activated receptor gamma coactivator 1beta (PGC-1beta), a novel PGC-1-related transcription coactivator associated with host cell factor. J. Biol. Chem., 2002, 277, 1645-1648.
35. Puigserver, P.; Wu, Z.; Park, C.W.; Graves, R.; Wright, M.; Spiegelman, B.M. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell, 1998, 92, 829-839.
36. Tudor, C.; Feige, J.N.; Pingali, H.; Lohray, V.B.; Wahli, W.; Desvergne, B.; Engelborghs, Y.; Gelman, L. Association with coregulators is the major determinant governing peroxisome proliferator-activated receptor mobility in living cells. J. Biol. Chem., 2007, 282, 4417-4426.
37. Devchand, P.R.; Keller, H.; Peters, J.M.; Vazquez, M.; Gonzalez, F.J.; Wahli, W. The PPARalpha-leukotriene B4 pathway to inflammation control. Nature, 1996, 384, 39-43.
38. Hostetler, H.A.; Petrescu, A.D.; Kier, A.B.; Schroeder, F. Peroxisome proliferator-activated receptor alpha interacts with high affinity and is conformationally responsive to endogenous ligands. J. Biol. Chem., 2005, 280, 18667-18682.
39. Chakravarthy, M.V.; Lodhi, I.J.; Yin, L.; Malapaka, R.R.; Xu, H.E.; Turk, J.; Semenkovich, C.F. Identification of a physiologically relevant endogenous ligand for PPARalpha in liver. Cell, 2009, 138, 476-488.
40. Brash, A.R. Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate. J. Biol. Chem., 1999, 274, 23679-23682.
41. Crisafulli, C.; Cuzzocrea, S. The role of endogenous and exogenous ligands for the peroxisome proliferator-activated receptor alpha (PPAR-alpha) in the regulation of inflammation in macrophages. Shock, 2009, 32, 62-73.
42. Ng, V.Y.; Huang, Y.; Reddy, L.M.; Falck, J.R.; Lin, E.T.; Kroetz, D.L. Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha. Drug Metab. Dispos., 2007, 35, 1126-1134.
43. Reddy, J.K. Peroxisome proliferators and peroxisome proliferator- activated receptor alpha: biotic and xenobiotic sensing. Am. J. Pathol., 2004, 164, 2305-2321.
44. Pyper, S.R.; Viswakarma, N.; Yu, S.; Reddy, J.K. PPARalpha: energy combustion, hypolipidemia, inflammation and cancer. Nucl. Recept. Signal., 2010, 8, e002.
45. Bays, H.; Stein, E.A. Pharmacotherapy for dyslipidaemia-current therapies and future agents. Expert Opin. Pharmacother., 2003, 4, 1901-1938.
46. Lefebvre, P.; Chinetti, G.; Fruchart, J.C.; Staels, B. Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J. Clin. Invest., 2006, 116, 571-580.
47. Marx, N.; Duez, H.; Fruchart, J.C.; Staels, B. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells. Circulation Res., 2004, 94, 1168-1178.
48. Kane, C.D.; Stevens, K.A.; Fischer, J.E.; Haghpassand, M.; Royer, L.J.; Aldinger, C.; Landschulz, K.T.; Zagouras, P.; Bagley, S.W.; Hada, W., et al. Molecular characterization of novel and selective peroxisome proliferator-activated receptor alpha agonists with robust hypolipidemic activity in vivo. Mol. Pharmacol., 2009, 75, 296-306.
49. Cariello, N.F.; Romach, E.H.; Colton, H.M.; Ni, H.; Yoon, L.; Falls, J.G.; Casey, W.; Creech, D.; Anderson, S.P.; Benavides, G.R., et al. Gene expression profiling of the PPAR-alpha agonist ciprofibrate in the cynomolgus monkey liver. Toxicol. Sci., 2005, 88, 250-264.
50. Bookout, A.L.; Jeong, Y.; Downes, M.; Yu, R.T.; Evans, R.M.; Mangelsdorf, D.J. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell, 2006, 126, 789-799.
51. Braissant, O.; Foufelle, F.; Scotto, C.; Dauca, M.; Wahli, W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology, 1996, 137, 354-366.
52. Inoue, J.; Satoh, S.; Kita, M.; Nakahara, M.; Hachimura, S.; Miyata, M.; Nishimaki-Mogami, T.; Sato, R. PPARalpha gene expression is up-regulated by LXR and PXR activators in the small intestine. Biochem. Biophys. Res. Commun., 2008, 371, 675-678.
53. Lee, Y.; Yu, X.; Gonzales, F.; Mangelsdorf, D.J.; Wang, M.Y.; Richardson, C.; Witters, L.A.; Unger, R.H. PPAR alpha is necessary for the lipopenic action of hyperleptinemia on white adipose and liver tissue. Proc. Natl Acad. Sci. USA, 2002, 99, 11848-11853.
54. Kelly, L.J.; Vicario, P.P.; Thompson, G.M.; Candelore, M.R.; Doebber, T.W.; Ventre, J.; Wu, M.S.; Meurer, R.; Forrest, M.J.; Conner, M.W., et al. Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression. Endocrinology, 1998, 139, 4920-4927.
55. Kersten, S.; Seydoux, J.; Peters, J.M.; Gonzalez, F.J.; Desvergne, B.; Wahli, W. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J. Clin. Invest., 1999, 103, 1489-1498.
56. Poynter, M.E.; Daynes, R.A. Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor-kappaB signaling, and reduces inflammatory cytokine production in aging. J. Biol. Chem., 1998, 273, 32833-32841.
57. Pineda Torra, I.; Jamshidi, Y.; Flavell, D.M.; Fruchart, J.C.; Staels, B. Characterization of the human PPARalpha promoter: identification of a functional nuclear receptor response element. Molecular Endo., 2002, 16, 1013-1028.
58. Corton, J.C.; Anderson, S.P.; Stauber, A. Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators. Ann. Rev. Pharmacol. Toxicol., 2000, 40, 491-518.
59. Rigamonti, E.; Chinetti-Gbaguidi, G.; Staels, B. Regulation of macrophage functions by PPAR-alpha, PPAR-gamma, and LXRs in mice and men. Arterioscl. Thromb. Vasc. Biol., 2008, 28, 1050-1059.
60. Genini, D.; Carbone, G.M.; Catapano, C.V. Multiple Interactions between Peroxisome Proliferators-Activated Receptors and the Ubiquitin-Proteasome System and Implications for Cancer Pathogenesis. PPAR Res., 2008, 2008, 195065.
61. Shalev, A.; Siegrist-Kaiser, C.A.; Yen, P.M.; Wahli, W.; Burger, A.G.; Chin, W.W.; Meier, C.A. The peroxisome proliferator-activated receptor alpha is a phosphoprotein: regulation by insulin. Endocrinology, 1996, 137, 4499-4502.
62. Barger, P.M.; Browning, A.C.; Garner, A.N.; Kelly, D.P. p38 mitogen-activated protein kinase activates peroxisome proliferator-activated receptor alpha: a potential role in the cardiac metabolic stress response. J.Biol. Chem., 2001, 276, 44495-44501.
63. Blanquart, C.; Mansouri, R.; Paumelle, R.; Fruchart, J.C.; Staels, B.; Glineur, C. The protein kinase C signaling pathway regulates a molecular switch between transactivation and transrepression activity of the peroxisome proliferator-activated receptor alpha. Mol. Endo., 2004, 18, 1906-1918.
64. Lee, S.S.; Pineau, T.; Drago, J.; Lee, E.J.; Owens, J.W.; Kroetz, D.L.; Fernandez-Salguero, P.M.; Westphal, H.; Gonzalez, F.J. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol., 1995, 15, 3012-3022.
65. Frohnert, B.I.; Hui, T.Y.; Bernlohr, D.A. Identification of a functional peroxisome proliferator-responsive element in the murine fatty acid transport protein gene. J. Biol. Chem., 1999, 274, 3970-3977.
66. Martin, G.; Schoonjans, K.; Lefebvre, A.M.; Staels, B.; Auwerx, J. Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators. J. Biol. Chem., 1997, 272, 28210-28217.
67. Motojima, K.; Passilly, P.; Peters, J.M.; Gonzalez, F.J.; Latruffe, N. Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner. J. Biol. Chem., 1998, 273, 16710-16714.
68. Schoonjans, K.; Watanabe, M.; Suzuki, H.; Mahfoudi, A.; Krey, G.; Wahli, W.; Grimaldi, P.; Staels, B.; Yamamoto, T.; Auwerx, J. Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter. J. Biol. Chem., 1995, 270, 19269-19276.
69. Mandard, S.; Muller, M.; Kersten, S. Peroxisome proliferator-activated receptor alpha target genes. Cell. Mol. Life Sci., 2004, 61, 393-416.
70. Coleman, R.A.; Lewin, T.M.; Van Horn, C.G.; Gonzalez-Baro, M.R. Do long-chain acyl-CoA synthetases regulate fatty acid entry into synthetic versus degradative pathways? J. Nutr., 2002, 132, 2123-2126.
71. Barrero, M.J.; Camarero, N.; Marrero, P.F.; Haro, D. Control of human carnitine palmitoyltransferase II gene transcription by peroxisome proliferator-activated receptor through a partially conserved peroxisome proliferator-responsive element. Biochem. J., 2003, 369, 721-729.
72. Fourcade, S.; Savary, S.; Albet, S.; Gauthe, D.; Gondcaille, C.; Pineau, T.; Bellenger, J.; Bentejac, M.; Holzinger, A.; Berger, J., et al. Fibrate induction of the adrenoleukodystrophy-related gene (ABCD2): promoter analysis and role of the peroxisome proliferator-activated receptor PPARalpha. Eur. J. Biochem., 2001, 268, 3490-3500.
73. Gulick, T.; Cresci, S.; Caira, T.; Moore, D.D.; Kelly, D.P. The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc. Natl Acad. Sci. USA, 1994, 91, 11012-11016.
74. Reddy, J.K.; Hashimoto, T. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. Ann. Rev. Nutr., 2001, 21, 193-230.
75. Hunt, M.; Lindquist, P.J.; Nousiainen, S.; Svensson, T.L.; Diczfalusy, U.; Alexson, S.E. Cloning and regulation of peroxisome proliferator-induced acyl-CoA thioesterases from mouse liver. Adv. Exp. Med. Biol., 1999, 466, 195-200.
76. Hashimoto, T.; Fujita, T.; Usuda, N.; Cook, W.; Qi, C.; Peters, J.M.; Gonzalez, F.J.; Yeldandi, A.V.; Rao, M.S.; Reddy, J.K. Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor alpha and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype. J. Biol. Chem., 1999, 274, 19228-19236.
77. Castelein, H.; Gulick, T.; Declercq, P.E.; Mannaerts, G.P.; Moore, D.D.; Baes, M.I. The peroxisome proliferator activated receptor regulates malic enzyme gene expression. J. Biol. Chem., 1994, 269, 26754-26758.
78. Hebbachi, A.M.; Knight, B.L.; Wiggins, D.; Patel, D.D.; Gibbons, G.F. Peroxisome proliferator-activated receptor alpha deficiency abolishes the response of lipogenic gene expression to re-feeding: restoration of the normal response by activation of liver X receptor alpha. J. Biol. Chem., 2008, 283, 4866-4876.
79. Vu-Dac, N.; Schoonjans, K.; Kosykh, V.; Dallongeville, J.; Fruchart, J.C.; Staels, B.; Auwerx, J. Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor. J. Clin. Invest., 1995, 96, 741-750.
80. Vu-Dac, N.; Schoonjans, K.; Laine, B.; Fruchart, J.C.; Auwerx, J.; Staels, B. Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element. J. Biol. Chem., 1994, 269, 31012-31018.
81. Peters, J.M.; Hennuyer, N.; Staels, B.; Fruchart, J.C.; Fievet, C.; Gonzalez, F.J.; Auwerx, J. Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice. J. Biol. Chem., 1997, 272, 27307-27312.
82. Staels, B.; Peinado-Onsurbe, J.; Auwerx, J. Down-regulation of hepatic lipase gene expression and activity by fenofibrate. Biochim. Biophys. Acta, 1992, 1123, 227-230.
83. Staels, B.; van Tol, A.; Skretting, G.; Auwerx, J. Lecithin: cholesterol acyltransferase gene expression is regulated in a tissue-selective manner by fibrates. J. Lipid Res., 1992, 33, 727-735.
84. Bouly, M.; Masson, D.; Gross, B.; Jiang, X.C.; Fievet, C.; Castro, G.; Tall, A.R.; Fruchart, J.C.; Staels, B.; Lagrost, L., et al. Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrate. J. Biol. Chem., 2001, 276, 25841-25847.
85. Mardones, P.; Pilon, A.; Bouly, M.; Duran, D.; Nishimoto, T.; Arai, H.; Kozarsky, K.F.; Altayo, M.; Miquel, J.F.; Luc, G., et al. Fibrates down-regulate hepatic scavenger receptor class B type I protein expression in mice. J. Biol. Chem., 2003, 278, 7884-7890.
86. Heller, F.; Harvengt, C. Effects of clofibrate, bezafibrate, fenofibrate and probucol on plasma lipolytic enzymes in normolipaemic subjects. Eur. J. Clin. Pharmacol., 1983, 25, 57-63.
87. Malmendier, C.L.; Lontie, J.F.; Delcroix, C.; Dubois, D.Y.; Magot, T.; De Roy, L. Apolipoproteins C-II and C-III metabolism in hypertriglyceridemic patients. Effect of a drastic triglyceride reduction by combined diet restriction and fenofibrate administration. Atherosclerosis, 1989, 77, 139-149.
88. Chinetti, G.; Gbaguidi, F.G.; Griglio, S.; Mallat, Z.; Antonucci, M.; Poulain, P.; Chapman, J.; Fruchart, J.C.; Tedgui, A.; Najib-Fruchart, J., et al. CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors. Circulation, 2000, 101, 2411-2417.
89. Chinetti, G.; Lestavel, S.; Bocher, V.; Remaley, A.T.; Neve, B.; Torra, I.P.; Teissier, E.; Minnich, A.; Jaye, M.; Duverger, N., et al. PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat. Med., 2001, 7, 53-58.
90. Chinetti, G.; Lestavel, S.; Fruchart, J.C.; Clavey, V.; Staels, B. Peroxisome proliferator-activated receptor alpha reduces cholesterol esterification in macrophages. Circulation Res., 2003, 92, 212-217.
91. Peeters, A.; Baes, M. Role of PPARalpha in Hepatic Carbohydrate Metabolism. PPAR Res., 2010, 2010.
92. Edgar, A.D.; Tomkiewicz, C.; Costet, P.; Legendre, C.; Aggerbeck, M.; Bouguet, J.; Staels, B.; Guyomard, C.; Pineau, T.; Barouki, R. Fenofibrate modifies transaminase gene expression via a peroxisome proliferator activated receptor alpha-dependent pathway. Toxicol. Lett., 1998, 98, 13-23.
93. Kersten, S.; Mandard, S.; Escher, P.; Gonzalez, F.J.; Tafuri, S.; Desvergne, B.; Wahli, W. The peroxisome proliferator-activated receptor alpha regulates amino acid metabolism. FASEB J., 2001, 15, 1971-1978.
94. Ricote, M.; Glass, C.K. PPARs and molecular mechanisms of transrepression. Biochim. Biophys. Acta, 2007, 1771, 926-935.
95. Staels, B.; Maes, M.; Zambon, A. Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease. Nat Clin Pract Cardiovasc Med, 2008, 5, 542-553.
96. Zandbergen, F.; Plutzky, J. PPARalpha in atherosclerosis and inflammation. Biochim. Biophys. Acta, 2007, 1771, 972-982.
97. Reddy, J.K.; Chu, R. Peroxisome proliferator-induced pleiotropic responses: pursuit of a phenomenon. Ann. N Y Acad. Sci., 1996, 804, 176-201.
98. Chen, H.H.; Sue, Y.M.; Chen, C.H.; Hsu, Y.H.; Hou, C.C.; Cheng, C.Y.; Lin, S.L.; Tsai, W.L.; Chen, T.W.; Chen, T.H. Peroxisome proliferator-activated receptor alpha plays a crucial role in Lcarnitine anti-apoptosis effect in renal tubular cells. Nephrol. Dial. Transpl., 2009, 24, 3042-3049.
99. Peters, J.M.; Cheung, C.; Gonzalez, F.J. Peroxisome proliferator- activated receptor-alpha and liver cancer: where do we stand? J. Mol.Med., 2005, 83, 774-785.
100. Bugge, A.; Mandrup, S. Molecular Mechanisms and Genome-Wide Aspects of PPAR Subtype Specific Transactivation. PPAR Res., 2010, 2010.
101. Miyata, K.S.; Zhang, B.; Marcus, S.L.; Capone, J.P.; Rachubinski, R.A. Chicken ovalbumin upstream promoter transcription factor (COUP-TF) binds to a peroxisome proliferator-responsive element and antagonizes peroxisome proliferator-mediated signaling. J. Biol. Chem., 1993, 268, 19169-19172.
102. Miller, R.T.; Scappino, L.A.; Long, S.M.; Corton, J.C. Role of thyroid hormones in hepatic effects of peroxisome proliferators. Toxicol. Pathol., 2001, 29, 149-155.
103. Costa, R.H.; Grayson, D.R.; Darnell, J.E., Jr. Multiple hepatocyte-enriched nuclear factors function in the regulation of transthyretin and alpha 1-antitrypsin genes. Mol. Cell. Biol., 1989, 9, 1415-1425.
104. Costa, R.H.; Van Dyke, T.A.; Yan, C.; Kuo, F.; Darnell, J.E., Jr. Similarities in transthyretin gene expression and differences in transcription factors: liver and yolk sac compared to choroid plexus. Proc. Natl Acad. Sci. USA, 1990, 87, 6589-6593.
105. Sladek, F.M.; Zhong, W.M.; Lai, E.; Darnell, J.E., Jr. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev., 1990, 4, 2353-2365.
106. Drewes, T.; Senkel, S.; Holewa, B.; Ryffel, G.U. Human hepatocyte nuclear factor 4 isoforms are encoded by distinct and differentially expressed genes. Mol. Cell. Biol., 1996, 16, 925-931.
107. Schrem, H.; Klempnauer, J.; Borlak, J. Liver-enriched transcription factors in liver function and development. Part I: the hepatocyte nuclear factor network and liver-specific gene expression. Pharmacol. Rev., 2002, 54, 129-158.
108. Chen, W.S.; Manova, K.; Weinstein, D.C.; Duncan, S.A.; Plump, A.S.; Prezioso, V.R.; Bachvarova, R.F.; Darnell, J.E., Jr. Disruption of the HNF-4 gene, expressed in visceral endoderm, leads to cell death in embryonic ectoderm and impaired gastrulation of mouse embryos. Genes Dev., 1994, 8, 2466-2477.
109. Hayhurst, G.P.; Lee, Y.H.; Lambert, G.; Ward, J.M.; Gonzalez, F.J. Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol. Cell.Biol., 2001, 21, 1393-1403.
110. Harries, L.W.; Locke, J.M.; Shields, B.; Hanley, N.A.; Hanley, K.P.; Steele, A.; Njolstad, P.R.; Ellard, S.; Hattersley, A.T. The diabetic phenotype in HNF4A mutation carriers is moderated by the expression of HNF4A isoforms from the P1 promoter during fetal development. Diabetes, 2008, 57, 1745-1752.
111. Duncan, S.A.; Manova, K.; Chen, W.S.; Hoodless, P.; Weinstein, D.C.; Bachvarova, R.F.; Darnell, J.E., Jr. Expression of transcription factor HNF-4 in the extraembryonic endoderm, gut, and nephrogenic tissue of the developing mouse embryo: HNF-4 is a marker for primary endoderm in the implanting blastocyst. Proc. Natl Acad. Sci. USA, 1994, 91, 7598-7602.
112. Huang, J.; Levitsky, L.L.; Rhoads, D.B. Novel P2 promoter-derived HNF4alpha isoforms with different N-terminus generated by alternate exon insertion. Exp. Cell Res., 2009, 315, 1200-1211.
113. Torres-Padilla, M.E.; Fougere-Deschatrette, C.; Weiss, M.C. Expression of HNF4alpha isoforms in mouse liver development is regulated by sequential promoter usage and constitutive 3' end splicing. Mech. Develop., 2001, 109, 183-193.
114. Kanazawa, T.; Konno, A.; Hashimoto, Y.; Kon, Y. Expression of hepatocyte nuclear factor 4alpha in developing mice. Anat. Histol. Embryol., 2009, 38, 34-41.
115. Dean, S.; Tang, J.I.; Seckl, J.R.; Nyirenda, M.J. Developmental and tissue-specific regulation of hepatocyte nuclear factor 4-alpha (HNF4-alpha) isoforms in rodents. Gene Express., 2010, 14, 337-344.
116. Hadzopoulou-Cladaras, M.; Kistanova, E.; Evagelopoulou, C.; Zeng, S.; Cladaras, C.; Ladias, J.A. Functional domains of the nuclear receptor hepatocyte nuclear factor 4. J. Biol. Chem., 1997, 272, 539-550.
117. Iordanidou, P.; Aggelidou, E.; Demetriades, C.; Hadzopoulou-Cladaras, M. Distinct amino acid residues may be involved in coactivator and ligand interactions in hepatocyte nuclear factor-4alpha. J. Biol. Chem., 2005, 280, 21810-21819.
118. Eeckhoute, J.; Briche, I.; Kurowska, M.; Formstecher, P.; Laine, B. Hepatocyte nuclear factor 4 alpha ligand binding and F domains mediate interaction and transcriptional synergy with the pancreatic islet LIM HD transcription factor Isl1. J.Mol. Biol., 2006, 364, 567-581.
119. Ruse, M.D., Jr.; Privalsky, M.L.; Sladek, F.M. Competitive cofactor recruitment by orphan receptor hepatocyte nuclear factor 4alpha1: modulation by the F domain. Mol. Cell. Biol., 2002, 22, 1626-1638.
120. Bolotin, E.; Liao, H.; Ta, T.C.; Yang, C.; Hwang-Verslues, W.; Evans, J.R.; Jiang, T.; Sladek, F.M. Integrated approach for the identification of human hepatocyte nuclear factor 4alpha target genes using protein binding microarrays. Hepatology, 2010, 51, 642-653.
121. Jiang, G.; Nepomuceno, L.; Yang, Q.; Sladek, F.M. Serine/threonine phosphorylation of orphan receptor hepatocyte nuclear factor 4. Arch. Biochem. Biophys., 1997, 340, 1-9.
122. Jiang, G.; Nepomuceno, L.; Hopkins, K.; Sladek, F.M. Exclusive homodimerization of the orphan receptor hepatocyte nuclear factor 4 defines a new subclass of nuclear receptors. Mol.Cell.Biol., 1995, 15, 5131-5143.
123. Benoit, G.; Cooney, A.; Giguere, V.; Ingraham, H.; Lazar, M.; Muscat, G.; Perlmann, T.; Renaud, J.P.; Schwabe, J.; Sladek, F., et al. International Union of Pharmacology. LXVI. Orphan nuclear receptors. Pharmacol. Rev. 2006, 58, 798-836.
124. Duda, K.; Chi, Y.I.; Shoelson, S.E. Structural basis for HNF-4alpha activation by ligand and coactivator binding. J. Biol. Chem., 2004, 279, 23311-23316.
125. Dell, H.; Hadzopoulou-Cladaras, M. CREB-binding protein is a transcriptional coactivator for hepatocyte nuclear factor-4 and enhances apolipoprotein gene expression. J. Biol. Chem., 1999, 274, 9013-9021.
126. Yoon, J.C.; Puigserver, P.; Chen, G.; Donovan, J.; Wu, Z.; Rhee, J.; Adelmant, G.; Stafford, J.; Kahn, C.R.; Granner, D.K., et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature, 2001, 413, 131-138.
127. Maeda, Y.; Rachez, C.; Hawel, L., 3rd; Byus, C.V.; Freedman, L.P.; Sladek, F.M. Polyamines modulate the interaction between nuclear receptors and vitamin D receptor-interacting protein 205. Mol. Endo., 2002, 16, 1502-1510.
128. Iwahashi, H.; Yamagata, K.; Yoshiuchi, I.; Terasaki, J.; Yang, Q.; Fukui, K.; Ihara, A.; Zhu, Q.; Asakura, T.; Cao, Y., et al. Thyroid hormone receptor interacting protein 3 (trip3) is a novel coactivator of hepatocyte nuclear factor-4alpha. Diabetes, 2002, 51, 910-914.
129. Li, T.; Chiang, J.Y. Rifampicin induction of CYP3A4 requires pregnane X receptor cross talk with hepatocyte nuclear factor 4alpha and coactivators, and suppression of small heterodimer partner gene expression. Drug Metab. Dispos., 2006, 34, 756-764.
130. Namciu, S.J.; Friedman, R.D.; Marsden, M.D.; Sarausad, L.M.; Jasoni, C.L.; Fournier, R.E. Sequence organization and matrix attachment regions of the human serine protease inhibitor gene cluster at 14q32.1. Mamm. Genome, 2004, 15, 162-178.
131. Bulla, G.A.; Fournier, R.E. Direct selection of hepatoma cell variants deficient in alpha 1-antitrypsin gene expression. Som. Cell Mol. Genet., 1992, 18, 361-370.
132. Bulla, G.A.; Fournier, R.E. Genetic analysis of a transcriptional activation pathway by using hepatoma cell variants. Mol. Cell.Biol., 1994, 14, 7086-7094.
133. Rollini, P.; Fournier, R.E. The HNF-4/HNF-1alpha transactivation cascade regulates gene activity and chromatin structure of the human serine protease inhibitor gene cluster at 14q32.1. Proc. Natl Acad. Sci. USA, 1999, 96, 10308-10313.
134. Baxter, E.W.; Cummings, W.J.; Fournier, R.E. Formation of a large, complex domain of histone hyperacetylation at human 14q32.1 requires the serpin locus control region. Nucl. Ac. Res, 2005, 33, 3313-3322.
135. Zhao, H.; Friedman, R.D.; Fournier, R.E. The locus control region activates serpin gene expression through recruitment of liverspecific transcription factors and RNA polymerase II. Mol. Cell. Biol., 2007, 27, 5286-5295.
136. Misawa, K.; Horiba, T.; Arimura, N.; Hirano, Y.; Inoue, J.; Emoto, N.; Shimano, H.; Shimizu, M.; Sato, R. Sterol regulatory elementbinding protein-2 interacts with hepatocyte nuclear factor-4 to enhance sterol isomerase gene expression in hepatocytes. J. Biol. Chem., 2003, 278, 36176-36182.
137. Eeckhoute, J.; Formstecher, P.; Laine, B. Hepatocyte nuclear factor 4alpha enhances the hepatocyte nuclear factor 1alpha-mediated activation of transcription. Nucl. Acid Res., 2004, 32, 2586-2593.
138. Ktistaki, E.; Talianidis, I. Chicken ovalbumin upstream promoter transcription factors act as auxiliary cofactors for hepatocyte nuclear factor 4 and enhance hepatic gene expression. Mol. Cell. Biol., 1997, 17, 2790-2797.
139. Hwang-Verslues, W.W.; Sladek, F.M. Nuclear receptor hepatocyte nuclear factor 4alpha1 competes with oncoprotein c-Myc for control of the p21/WAF1 promoter. Mol. Endo., 2008, 22, 78-90.
140. Takahashi, S.; Matsuura, N.; Kurokawa, T.; Takahashi, Y.; Miura, T. Co-operation of the transcription factor hepatocyte nuclear factor-4 with Sp1 or Sp3 leads to transcriptional activation of the human haem oxygenase-1 gene promoter in a hepatoma cell line. Biochem. J., 2002, 367, 641-652.
141. Sumi, K.; Tanaka, T.; Uchida, A.; Magoori, K.; Urashima, Y.; Ohashi, R.; Ohguchi, H.; Okamura, M.; Kudo, H.; Daigo, K., et al. Cooperative interaction between hepatocyte nuclear factor 4 alpha and GATA transcription factors regulates ATP-binding cassette sterol transporters ABCG5 and ABCG8. Mol. Cell. Biol., 2007, 27, 4248-4260.
142. Harnish, D.C.; Malik, S.; Kilbourne, E.; Costa, R.; Karathanasis, S.K. Control of apolipoprotein AI gene expression through synergistic interactions between hepatocyte nuclear factors 3 and 4. J. Biol. Chem., 1996, 271, 13621-13628.
143. Beaudry, J.B.; Pierreux, C.E.; Hayhurst, G.P.; Plumb-Rudewiez, N.; Weiss, M.C.; Rousseau, G.G.; Lemaigre, F.P. Threshold levels of hepatocyte nuclear factor 6 (HNF-6) acting in synergy with HNF-4 and PGC-1alpha are required for time-specific gene expression during liver development. Mol. Cell. Biol., 2006, 26, 6037-6046.
144. Yamamoto, T.; Shimano, H.; Nakagawa, Y.; Ide, T.; Yahagi, N.; Matsuzaka, T.; Nakakuki, M.; Takahashi, A.; Suzuki, H.; Sone, H., et al. SREBP-1 interacts with hepatocyte nuclear factor-4 alpha and interferes with PGC-1 recruitment to suppress hepatic gluconeogenic genes. J. Biol. Chem., 2004, 279, 12027-12035.
145. Bhalla, S.; Ozalp, C.; Fang, S.; Xiang, L.; Kemper, J.K. Ligand-activated pregnane X receptor interferes with HNF-4 signaling by targeting a common coactivator PGC-1alpha. Functional implications in hepatic cholesterol and glucose metabolism. J. Biol. Chem., 2004, 279, 45139-45147.
146. Onica, T.; Nichols, K.; Larin, M.; Ng, L.; Maslen, A.; Dvorak, Z.; Pascussi, J.M.; Vilarem, M.J.; Maurel, P.; Kirby, G.M. Dexamethasone-mediated up-regulation of human CYP2A6 involves the glucocorticoid receptor and increased binding of hepatic nuclear factor 4 alpha to the proximal promoter. Mol. Pharmacol., 2008, 73, 451-460.
147. Chou, W.C.; Prokova, V.; Shiraishi, K.; Valcourt, U.; Moustakas, A.; Hadzopoulou-Cladaras, M.; Zannis, V.I.; Kardassis, D. Mechanism of a transcriptional cross talk between transforming growth factor-beta-regulated Smad3 and Smad4 proteins and orphan nuclear receptor hepatocyte nuclear factor-4. Mol. Biol. Cell, 2003, 14, 1279-1294.
148. Suaud, L.; Hemimou, Y.; Formstecher, P.; Laine, B. Functional study of the E276Q mutant hepatocyte nuclear factor-4alpha found in type 1 maturity-onset diabetes of the young: impaired synergy with chicken ovalbumin upstream promoter transcription factor II on the hepatocyte nuclear factor-1 promoter. Diabetes, 1999, 48, 1162-1167.
149. Hertz, R.; Magenheim, J.; Berman, I.; Bar-Tana, J. Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4alpha. Nature, 1998, 392, 512-516.
150. Bogan, A.A.; Dallas-Yang, Q.; Ruse, M.D., Jr.; Maeda, Y.; Jiang, G.; Nepomuceno, L.; Scanlan, T.S.; Cohen, F.E.; Sladek, F.M. Analysis of protein dimerization and ligand binding of orphan receptor HNF4alpha. J. Mol.Biol., 2000, 302, 831-851.
151. Dhe-Paganon, S.; Duda, K.; Iwamoto, M.; Chi, Y.I.; Shoelson, S.E. Crystal structure of the HNF4 alpha ligand binding domain in complex with endogenous fatty acid ligand. J. Biol. Chem., 2002, 277, 37973-37976.
152. Wisely, G.B.; Miller, A.B.; Davis, R.G.; Thornquest, A.D., Jr.; Johnson, R.; Spitzer, T.; Sefler, A.; Shearer, B.; Moore, J.T.; Miller, A.B., et al. Hepatocyte nuclear factor 4 is a transcription factor that constitutively binds fatty acids. Structure, 2002, 10, 1225-1234.
153. Yuan, X.; Ta, T.C.; Lin, M.; Evans, J.R.; Dong, Y.; Bolotin, E.; Sherman, M.A.; Forman, B.M.; Sladek, F.M. Identification of an endogenous ligand bound to a native orphan nuclear receptor. PLoS One, 2009, 4, e5609.
154. Le Guevel, R.; Oger, F.; Lecorgne, A.; Dudasova, Z.; Chevance, S.; Bondon, A.; Barath, P.; Simonneaux, G.; Salbert, G. Identification of small molecule regulators of the nuclear receptor HNF4alpha based on naphthofuran scaffolds. Bioorg. Med.Chem., 2009, 17, 7021-7030.
155. Petrescu, A.D.; Hertz, R.; Bar-Tana, J.; Schroeder, F.; Kier, A.B. Ligand specificity and conformational dependence of the hepatic nuclear factor-4alpha (HNF-4alpha). J. Biol. Chem., 2002, 277, 23988-23999.
156. Sheena, V.; Hertz, R.; Nousbeck, J.; Berman, I.; Magenheim, J.; Bar-Tana, J. Transcriptional regulation of human microsomal triglyceride transfer protein by hepatocyte nuclear factor-4alpha. J. Lipid Res., 2005, 46, 328-341.
157. Rufibach, L.E.; Duncan, S.A.; Battle, M.; Deeb, S.S. Transcriptional regulation of the human hepatic lipase (LIPC) gene promoter. J. Lipid Res., 2006, 47, 1463-1477.
158. Sladek, F.M. What are nuclear receptor ligands? Mol. Cell. Endo., 2010.
159. Jiang, S.; Tanaka, T.; Iwanari, H.; Hotta, H.; Yamashita, H.; Kumakura, J.; Watanabe, Y.; Uchiyama, Y.; Aburatani, H.; Hamakubo, T., et al. Expression and localization of P1 promoter-driven hepatocyte nuclear factor-4alpha (HNF4alpha) isoforms in human and rats. Nucl. Recept, 2003, 1, 5.
160. Sladek, F.M. Orphan receptor HNF-4 and liver-specific gene expression. Receptor, 1994, 4, 64.
161. Runge, D.; Runge, D.M.; Daskalakis, N.; Lubecki, K.A.; Bowen, W.C.; Michalopoulos, G.K. Matrix-mediated changes in the expression of HNF-4alpha isoforms and in DNA-binding activity of ARP-1 in primary cultures of rat hepatocytes. Biochem. Biophys. Res. Commun., 1999, 259, 651-655.
162. Xie, X.; Liao, H.; Dang, H.; Pang, W.; Guan, Y.; Wang, X.; Shyy, J.Y.; Zhu, Y.; Sladek, F.M. Down-regulation of hepatic HNF4alpha gene expression during hyperinsulinemia via SREBPs. Mol. Endo., 2009, 23, 434-443.
163. Guo, H.; Gao, C.; Mi, Z.; Wai, P.Y.; Kuo, P.C. Phosphorylation of Ser158 regulates inflammatory redox-dependent hepatocyte nuclear factor-4alpha transcriptional activity. Biochem. J., 2006, 394, 379-387.
164. Hong, Y.H.; Varanasi, U.S.; Yang, W.; Leff, T. AMP-activated protein kinase regulates HNF4alpha transcriptional activity by inhibiting dimer formation and decreasing protein stability. J. Biol. Chem., 2003, 278, 27495-27501.
165. Sun, K.; Montana, V.; Chellappa, K.; Brelivet, Y.; Moras, D.; Maeda, Y.; Parpura, V.; Paschal, B.M.; Sladek, F.M. Phosphorylation of a conserved serine in the deoxyribonucleic acid binding domain of nuclear receptors alters intracellular localization. Mol. Endo., 2007, 21, 1297-1311.
166. Viollet, B.; Kahn, A.; Raymondjean, M. Protein kinase Adependent phosphorylation modulates DNA-binding activity of hepatocyte nuclear factor 4. Mol. Cell. Biol., 1997, 17, 4208-4219.
167. Ktistaki, E.; Ktistakis, N.T.; Papadogeorgaki, E.; Talianidis, I. Recruitment of hepatocyte nuclear factor 4 into specific intranuclear compartments depends on tyrosine phosphorylation that affects its DNA-binding and transactivation potential. Proc. Natl Acad. Sci. USA, 1995, 92, 9876-9880.
168. Soutoglou, E.; Katrakili, N.; Talianidis, I. Acetylation regulates transcription factor activity at multiple levels. Mol. Cell, 2000, 5, 745-751.
169. Barrero, M.J.; Malik, S. Two functional modes of a nuclear receptor-recruited arginine methyltransferase in transcriptional activation. Mol. Cell, 2006, 24, 233-243.
170. Duncan, S.A.; Nagy, A.; Chan, W. Murine gastrulation requires HNF-4 regulated gene expression in the visceral endoderm: tetraploid rescue of Hnf-4(-/-) embryos. Development, 1997, 124, 279-287.
171. Li, J.; Ning, G.; Duncan, S.A. Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha. Genes Dev., 2000, 14, 464-474.
172. Battle, M.A.; Konopka, G.; Parviz, F.; Gaggl, A.L.; Yang, C.; Sladek, F.M.; Duncan, S.A. Hepatocyte nuclear factor 4alpha orchestrates expression of cell adhesion proteins during the epithelial transformation of the developing liver. Proc. Natl Acad. Sci. USA, 2006, 103, 8419-8424.
173. Parviz, F.; Matullo, C.; Garrison, W.D.; Savatski, L.; Adamson, J.W.; Ning, G.; Kaestner, K.H.; Rossi, J.M.; Zaret, K.S.; Duncan, S.A. Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis. Nature Genet., 2003, 34, 292-296.
174. Babeu, J.P.; Darsigny, M.; Lussier, C.R.; Boudreau, F. Hepatocyte nuclear factor 4alpha contributes to an intestinal epithelial phenotype in vitro and plays a partial role in mouse intestinal epithelium differentiation. Am. J. Physiol. Gastrointest. Liver Physiol., 2009, 297, G124-134.
175. Cattin, A.L.; Le Beyec, J.; Barreau, F.; Saint-Just, S.; Houllier, A.; Gonzalez, F.J.; Robine, S.; Pincon-Raymond, M.; Cardot, P.; Lacasa, M., et al. Hepatocyte nuclear factor 4alpha, a key factor for homeostasis, cell architecture, and barrier function of the adult intestinal epithelium. Mol.Cell. Biol., 2009, 29, 6294-6308.
176. Darsigny, M.; Babeu, J.P.; Dupuis, A.A.; Furth, E.E.; Seidman, E.G.; Levy, E.; Verdu, E.F.; Gendron, F.P.; Boudreau, F. Loss of hepatocyte-nuclear- factor-4alpha affects colonic ion transport and causes chronic inflammation resembling inflammatory bowel disease in mice. PLoS One, 2009, 4, e7609.
177. Garrison, W.D.; Battle, M.A.; Yang, C.; Kaestner, K.H.; Sladek, F.M.; Duncan, S.A. Hepatocyte nuclear factor 4alpha is essential for embryonic development of the mouse colon. Gastroenterology, 2006, 130, 1207-1220.
178. Odom, D.T.; Dowell, R.D.; Jacobsen, E.S.; Nekludova, L.; Rolfe, P.A.; Danford, T.W.; Gifford, D.K.; Fraenkel, E.; Bell, G.I.; Young, R.A. Core transcriptional regulatory circuitry in human hepatocytes. Mol. Syst. Biol., 2006, 2, 2006 0017.
179. Odom, D.T.; Zizlsperger, N.; Gordon, D.B.; Bell, G.W.; Rinaldi, N.J.; Murray, H.L.; Volkert, T.L.; Schreiber, J.; Rolfe, P.A.; Gifford, D.K., et al. Control of pancreas and liver gene expression by HNF transcription factors. Science, 2004, 303, 1378-1381.
180. Winrow, C.J.; Marcus, S.L.; Miyata, K.S.; Zhang, B.; Capone, J.P.; Rachubinski, R.A. Transactivation of the peroxisome proliferator-activated receptor is differentially modulated by hepatocyte nuclear factor-4. Gene Express., 1994, 4, 53-62.
181. Inoue, Y.; Peters, L.L.; Yim, S.H.; Inoue, J.; Gonzalez, F.J. Role of hepatocyte nuclear factor 4alpha in control of blood coagulation factor gene expression. J.Mol. Med., 2006, 84, 334-344.
182. Gonzalez, F.J. Regulation of hepatocyte nuclear factor 4 alpha-mediated transcription. Drug Metab Pharmacokinet, 2008, 23, 2-7.
183. Gupta, R.K.; Vatamaniuk, M.Z.; Lee, C.S.; Flaschen, R.C.; Fulmer, J.T.; Matschinsky, F.M.; Duncan, S.A.; Kaestner, K.H. The MODY1 gene HNF-4alpha regulates selected genes involved in insulin secretion. J.Clin. Invest., 2005, 115, 1006-1015.
184. Miura, A.; Yamagata, K.; Kakei, M.; Hatakeyama, H.; Takahashi, N.; Fukui, K.; Nammo, T.; Yoneda, K.; Inoue, Y.; Sladek, F.M., et al. Hepatocyte nuclear factor-4alpha is essential for glucose-stimulated insulin secretion by pancreatic beta-cells. J. Biol. Chem., 2006, 281, 5246-5257.
185. Reijnen, M.J.; Peerlinck, K.; Maasdam, D.; Bertina, R.M.; Reitsma, P.H. Hemophilia B Leyden: substitution of thymine for guanine at position -21 results in a disruption of a hepatocyte nuclear factor 4 binding site in the factor IX promoter. Blood, 1993, 82, 151-158.
186. Martinez-Jimenez, C.P.; Kyrmizi, I.; Cardot, P.; Gonzalez, F.J.; Talianidis, I. Hepatocyte nuclear factor 4alpha coordinates a transcription factor network regulating hepatic fatty acid metabolism. Mol. Cell. Biol., 2010, 30, 565-577.
187. Baumgart, E.; Vanhooren, J.C.; Fransen, M.; Marynen, P.; Puype, M.; Vandekerckhove, J.; Leunissen, J.A.; Fahimi, H.D.; Mannaerts, G.P.; van Veldhoven, P.P. Molecular characterization of the human peroxisomal branched-chain acyl-CoA oxidase: cDNA cloning, chromosomal assignment, tissue distribution, and evidence for the absence of the protein in Zellweger syndrome. Proc. Natl Acad. Sci. USA, 1996, 93, 13748-13753.
188. Van Veldhoven, P.P.; Vanhove, G.; Assselberghs, S.; Eyssen, H.J.; Mannaerts, G.P. Substrate specificities of rat liver peroxisomal acyl-CoA oxidases: palmitoyl-CoA oxidase (inducible acyl-CoA oxidase), pristanoyl-CoA oxidase (non-inducible acyl-CoA oxidase), and trihydroxycoprostanoyl-CoA oxidase. J. Biol. Chem., 1992, 267, 20065-20074.
189. Nishiyama, C.; Hi, R.; Osada, S.; Osumi, T. Functional interactions between nuclear receptors recognizing a common sequence element, the direct repeat motif spaced by one nucleotide (DR-1). J. Biochem., 1998, 123, 1174-1179.
190. Shin, M.; Kim, I.; Inoue, Y.; Kimura, S.; Gonzalez, F.J. Regulation of mouse hepatic alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase, a key enzyme in the tryptophan-nicotinamide adenine dinucleotide pathway, by hepatocyte nuclear factor 4alpha and peroxisome proliferator- activated receptor alpha. Mol. Pharmacol., 2006, 70, 1281-1290.
191. Ferdinandusse, S.; Denis, S.; Van Roermund, C.W.; Wanders, R.J.; Dacremont, G. Identification of the peroxisomal beta-oxidation enzymes involved in the degradation of long-chain dicarboxylic acids. J. Lipid Res., 2004, 45, 1104-1111.
192. Wanders, R.J.; Waterham, H.R. Biochemistry of mammalian peroxisomes revisited. Ann. Rev. Biochem., 2006, 75, 295-332.
193. Seedorf, U.; Raabe, M.; Ellinghaus, P.; Kannenberg, F.; Fobker, M.; Engel, T.; Denis, S.; Wouters, F.; Wirtz, K.W.; Wanders, R.J., et al. Defective peroxisomal catabolism of branched fatty acyl coenzyme A in mice lacking the sterol carrier protein-2/sterol carrier protein-x gene function. Genes Dev., 1998, 12, 1189-1201.
194. Hijikata, M.; Wen, J.K.; Osumi, T.; Hashimoto, T. Rat peroxisomal 3-ketoacyl-CoA thiolase gene. Occurrence of two closely related but differentially regulated genes. J. Biol. Chem., 1990, 265, 4600-4606.
195. Bodnar, A.G.; Rachubinski, R.A. Cloning and sequence determination of cDNA encoding a second rat liver peroxisomal 3-ketoacyl-CoA thiolase. Gene, 1990, 91, 193-199.
196. Nohammer, C.; El-Shabrawi, Y.; Schauer, S.; Hiden, M.; Berger, J.; Forss-Petter, S.; Winter, E.; Eferl, R.; Zechner, R.; Hoefler, G. cDNA cloning and analysis of tissue-specific expression of mouse peroxisomal straight-chain acyl-CoA oxidase. Eur. J. Biochem., 2000, 267, 1254-1260.
197. Desaint, S.; Hansmannel, F.; Clemencet, M.C.; Le Jossic-Corcos, C.; Nicolas-Frances, V.; Latruffe, N.; Cherkaoui-Malki, M. NFY interacts with the promoter region of two genes involved in the rat peroxisomal fatty acid beta-oxidation: the multifunctional protein type 1 and the 3-ketoacyl-CoA B thiolase. Lipids Health Dis., 2004, 3, 4.
198. Nicolas-Frances, V.; Dasari, V.K.; Abruzzi, E.; Osumi, T.; Latruffe, N. The peroxisome proliferator response element (PPRE) present at positions -681/-669 in the rat liver 3-ketoacyl-CoA thiolase B gene functionally interacts differently with PPARalpha and HNF-4. Biochem. Biophys. Res. Commun., 2000, 269, 347-351.
199. Chamouton, J.H., F.; Bonzo, J.A.; Clémencet, M.C.; Chevillard, G.; Battle, M.; Martin, P.; Pineau, T.; Duncan, S.; Gonzalez, F.J.; Latruffe, N; Mandard, S.; Nicolas-Francès V. The peroxisomal 3- keto-acyl-CoA thiolase B gene expression is under the dual control of PPARalpha and HNF4alpha in the liver. PPAR Res., 2010, 352957.
200. Bout, A.; Franse, M.M.; Collins, J.; Blonden, L.; Tager, J.M.; Benne, R. Characterization of the gene encoding human peroxisomal 3-oxoacyl-CoA thiolase (ACAA). No large DNA rearrangement in a thiolase-deficient patient. Biochim. Biophys. Acta, 1991, 1090, 43-51.
201. Bout, A.; Teunissen, Y.; Hashimoto, T.; Benne, R.; Tager, J.M. Nucleotide sequence of human peroxisomal 3-oxoacyl-CoA thiolase. Nucl. Ac. Res., 1988, 16, 10369.
202. Antonenkov, V.D.; Van Veldhoven, P.P.; Waelkens, E.; Mannaerts, G.P. Substrate specificities of 3-oxoacyl-CoA thiolase A and sterol carrier protein 2/3-oxoacyl-CoA thiolase purified from normal rat liver peroxisomes. Sterol carrier protein 2/3-oxoacyl-CoA thiolase is involved in the metabolism of 2-methyl-branched fatty acids and bile acid intermediates. J. Biol. Chem., 1997, 272, 26023-26031.
203. Gallegos, A.M.; Atshaves, B.P.; Storey, S.M.; Starodub, O.; Petrescu, A.D.; Huang, H.; McIntosh, A.L.; Martin, G.G.; Chao, H.; Kier, A.B., et al. Gene structure, intracellular localization, and functional roles of sterol carrier protein-2. Prog. Lipid Res., 2001, 40, 498-563.
204. Lopez, D.; Irby, R.B.; McLean, M.P. Peroxisome proliferator-activated receptor alpha induces rat sterol carrier protein x promoter activity through two peroxisome proliferator-response elements. Mol. Cell. Endo., 2003, 205, 169-184.
205. Hertz, R.; Bishara-Shieban, J.; Bar-Tana, J. Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III. J. Biol. Chem., 1995, 270, 13470-13475.
206. Hertz, R.; Seckbach, M.; Zakin, M.M.; Bar-Tana, J. Transcriptional suppression of the transferrin gene by hypolipidemic peroxisome proliferators. J. Biol. Chem., 1996, 271, 218-224.
207. Dongol, B.; Shah, Y.; Kim, I.; Gonzalez, F.J.; Hunt, M.C. The acyl-CoA thioesterase I is regulated by PPARalpha and HNF4alpha via a distal response element in the promoter. J. Lipid Res., 2007, 48, 1781-1791.
208. Palanker, L.; Tennessen, J.M.; Lam, G.; Thummel, C.S. Drosophila HNF4 regulates lipid mobilization and beta-oxidation. Cell Metab., 2009, 9, 228-239.
209. Louet, J.F.; Hayhurst, G.; Gonzalez, F.J.; Girard, J.; Decaux, J.F. The coactivator PGC-1 is involved in the regulation of the liver carnitine palmitoyltransferase I gene expression by cAMP in combination with HNF4 alpha and cAMP-response element-binding protein (CREB). J. Biol. Chem., 2002, 277, 37991-38000.
210. van der Leij, F.R.; Bloks, V.W.; Grefhorst, A.; Hoekstra, J.; Gerding, A.; Kooi, K.; Gerbens, F.; te Meerman, G.; Kuipers, F. Gene expression profiling in livers of mice after acute inhibition of betaoxidation. Genomics, 2007, 90, 680-689.
211. Rowley, C.W.; Staloch, L.J.; Divine, J.K.; McCaul, S.P.; Simon, T.C. Mechanisms of mutual functional interactions between HNF-4alpha and HNF-1alpha revealed by mutations that cause maturity onset diabetes of the young. Am. J. Physiol. Gastrointest. Liver Physiol., 2006, 290, G466-475.
212. Mitchell, S.M.; Gloyn, A.L.; Owen, K.R.; Hattersley, A.T.; Frayling, T.M. The role of the HNF4alpha enhancer in type 2 diabetes. Mol. Genet. Metab., 2002, 76, 148-151.
213. Jump, D.B.; Clarke, S.D. Regulation of gene expression by dietary fat. Ann. Rev. Nutr., 1999, 19, 63-90.
214. Liang, B.; Ferguson, K.; Kadyk, L.; Watts, J.L. The role of nuclear receptor NHR-64 in fat storage regulation in Caenorhabditis elegans. PLoS One, 2010, 5, e9869.
215. Pramfalk, C.; Karlsson, E.; Groop, L.; Rudel, L.L.; Angelin, B.; Eriksson, M.; Parini, P. Control of ACAT2 liver expression by HNF4 {alpha}: lesson from MODY1 patients. Arterioscl., Thromb. Vas. Biol., 2009, 29, 1235-1241.
216. Martin, P.G.; Guillou, H.; Lasserre, F.; Dejean, S.; Lan, A.; Pascussi, J.M.; Sancristobal, M.; Legrand, P.; Besse, P.; Pineau, T. Novel aspects of PPARalpha-mediated regulation of lipid and xenobiotic metabolism revealed through a nutrigenomic study. Hepatology, 2007, 45, 767-777.
217. Patsouris, D.; Reddy, J.K.; Muller, M.; Kersten, S. Peroxisome proliferator-activated receptor alpha mediates the effects of high-fat diet on hepatic gene expression. Endocrinology, 2006, 147, 1508-1516.